Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-2v3sqdxRecruiting
Single-blind, single-arm trial in burn injury, sponsored by Instituto de Saúde e Bem Estar da Mulher. Primary endpoints: Efficacy of Hycos Dérmico and Safety of Hycos Dérmico. Started Jun 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-2v3sqdx.